19th week of 2010 patent applcation highlights part 55 |
Patent application number | Title | Published |
20100121088 | Mineral/Organic Composite Material - The invention relates to a composite material comprising nanoparticles of at least one metal derivative and at least one type of carboxylic and/or sulfonic acid derivative organic compound chemically bound in a covalent manner with said nanoparticles by means of at least one carboxylic and/or sulfonic function. | 2010-05-13 |
20100121089 | Methods for preparing dioranozinc compounds - There are provided methods for preparing diorganozinc compounds of formula R | 2010-05-13 |
20100121090 | OPTICALLY ACTIVE ORGANIC ACIDATE-BRIDGED DINUCLEAR PLATINUM(II) COMPLEX - The present invention is an optically active organic acidate-bridged dinuclear platinum(II) complex represented by the general formula (I): | 2010-05-13 |
20100121091 | Processes of preparing asymmetric dinitrobenzamide mustard compounds, intermediate compounds useful therein and products obtained therefrom - The invention relates to methods of preparing compounds of formula (II) wherein Z represents —OR | 2010-05-13 |
20100121092 | PROCESS FOR PREPARING AN ALKENYLPHOSPHONIC ACID DERIVATIVE - Process for preparing an alkenylphosphonic acid derivative by reacting a phosphonic acid derivative with an alkyne in the presence of a complex catalyst system and a base whose conjugate acid has a pKa in dimethyl sulfoxide (25° C., 1 bar) of at least 6. | 2010-05-13 |
20100121093 | Method for dimethyl carbonate synthesis - There is provided a catalyst for dimethyl carbonate synthesis which has a high conversion rate under the supercritical condition of CO | 2010-05-13 |
20100121094 | METHODS FOR THE PREPARATION OF N-ISOBUTYL-N-(2-HYDROXY-3-AMINO-4-PHENYLBUTYL)-P-NITROBENZENESULFONYLAMID- E DERIVATIVES - A process for the preparation of N-isobutyl-N-(2-hydroxy-3-amino-4-phenylbutyl)-p-nitrobenzenesulfonylamide derivatives in which a (1-benzyl-2-hydroxy-3-isobutyl-amino-propyl)-carbamic acid derivative is reacted with a p-nitrophenylsulfonyl halide to provide the desired product in a high yield and degree of purity. | 2010-05-13 |
20100121095 | METHOD FOR PRODUCING DIHALO ACETOACETIC ALKYL ESTERS - The invention relates to a process for preparing alkyl dihaloacetoacetates of the formula (I) by reacting α,α-dihaloamines of the formula (III) with acetic esters of the formula (II) in the presence of bases. | 2010-05-13 |
20100121096 | ZEOLITE-CATALYZED PREPARATION OF ALPHA-HYDROXY CARBOXYLIC ACIDS AND ESTERS THEREOF - A process for the production of lactic acid and 2-hydroxy-3-butenoic acid or esters thereof by conversion of glucose, fructose, sucrose, xylose and glycolaldehyde dissolved in a solvent in presence of a solid Lewis acidic catalyst. | 2010-05-13 |
20100121097 | RECOVERY METHOD OF PYROLYSIS PRODUCT OF RESIN - A method of recovering pyrolysis products of resin of the present invention includes cooling gaseous pyrolysis products generated from pyrolysis of the resin in a pyrolysis tank to recover the resin as liquid pyrolysis products. The method includes the following steps (1) to (4): (1) continuously feeding fluidization gas, heated solid particles, and a resin into the pyrolysis tank to fluidize the solid particles and the resin by the fluidization gas; (2) continuously feeding the resin into the pyrolysis tank from a position which is ½ or less of the height of a solid particle layer in the pyrolysis tank in a stationary state; (3) continuously discharging the solid particles from a position lower than the height of a feeding position of the resin; and (4) heating the discharged solid particles in a heating furnace and then feeding the heated solid particles into the pyrolysis tank. | 2010-05-13 |
20100121098 | PROCESS FOR THE CARBONYLATION OF DIMTHYL ETHER - Production of methyl acetate by carbonylating a dimethyl ether feed with carbon monoxide under substantially anhydrous conditions, in the presence of a mordenite catalyst which contains copper and/or silver and 0.05 to 10 mol % platinum relative to aluminium. | 2010-05-13 |
20100121099 | PROCESS FOR THE CARBONYLATION OF DIMETHYL ETHER - Production of methyl acetate by carbonylating a dimethyl ether feed with carbon monoxide under substantially anhydrous conditions, in the presence of a zeolite catalyst at a temperature in the range 240° C. to 350° C. and in the presence of hydrogen. | 2010-05-13 |
20100121100 | Supported palladium-gold catalysts and preparation of vinyl acetate therewith - Disclosed is a catalyst. The catalyst comprises palladium, gold, and a support comprising titanium dioxide and tungsten trioxide. The support preferably comprises from 75 wt % to 99 wt % of titanium dioxide and from 1 wt % to 25 wt % of tungsten trioxide. A method for preparing the catalyst is also disclosed. The method comprises impregnating the support with a palladium compound and a gold compound, calcining the impregnated support, and then reducing the calcined support. Further disclosed is a method for preparing vinyl acetate with the catalyst. The catalyst exhibits improved catalytic activity and selectivity. | 2010-05-13 |
20100121101 | Methanol carbonylation with improved aldehyde removal - Methanol carbonylation with improved aldehyde removal includes: (a) scrubbing light ends and aldehyde impurity from vent gas with an absorber solvent; (b) stripping absorbed light ends and aldehyde impurity from the absorber solvent to provide a vent-recovered light ends stream; (c) purifying the vent-recovered light ends stream to remove aldehyde impurity; and (d) recycling purified light ends from the vent-recovered light ends stream to the production system. | 2010-05-13 |
20100121102 | PROCESS FOR PRODUCING METHIONINE - A process for producing methionine advantageously in view of cost, while efficiently recovering useful components, is provided including the following steps: (1) hydrolyzing 5-[2-(methylthio)ethyl]imidazolidine-2,4-dione in the presence of a basic potassium compound; (2) introducing carbon dioxide into the reaction solution obtained in the step (1) to thereby precipitate methionine, and separating the resulting slurry into a precipitate and a mother liquor; (3) concentrating the mother liquor obtained in the step (2), mixing the resulting concentrate with a lower alcohol, introducing carbon dioxide into the resulting mixture to thereby precipitate methionine and potassium hydrogencarbonate, and separating the resulting slurry into a precipitate and a mother liquor; and (4) concentrating the mother liquor obtained in the step (3), treating the resulting concentrate by heating at a temperature of from 150 to 200° C., and recycling the treated solution for use in step (2). | 2010-05-13 |
20100121103 | PROCESS FOR PRODUCING METHIONINE - A process for producing methionine advantageously in view of cost, while efficiently recovering useful components, is provided, including the following steps: (1) hydrolyzing 5-[2-(methylthio)ethyl]imidazolidine-2,4-dione in the presence of a basic potassium compound; (2) introducing carbon dioxide into the reaction solution obtained in step (1) to thereby precipitate methionine, and separating the resulting slurry into a precipitate and a mother liquor; (3) concentrating the mother liquor obtained in step (2), mixing the resulting concentrate with a lower alcohol, introducing carbon dioxide into the resulting mixture to thereby precipitate methionine and potassium hydrogencarbonate, and separating the resulting slurry into a precipitate and a mother liquor; and (4) concentrating the mother liquor obtained in step (3), treating the resulting concentrate by heating at a temperature of from 150 to 200° C., and recycling the treated solution for use in step (3). | 2010-05-13 |
20100121104 | PROCESS FOR PRODUCING METHIONINE - A process for producing methionine, while corrosion of a pipe and a reaction vessel is well inhibited, is provided including the following steps (1) to (3), wherein a content of thiols in 3-methylthiopropanal is 500 ppm or less, based on the propanal, and a content of hydrogen sulfide in 3-methylthiopropanal is 60 ppm or less, based on the propanal; step (1) in which 3-methylthiopropanal is reacted with hydrogen cyanide in the presence of a base to give 2-hydroxy-4-methylthiobutanenitrile; step (2) in which the 2-hydroxy-4-methylthiobutanenitrile obtained in step (1) is reacted with ammonium carbonate to give 5-(β-methylmercaptoethyl)hydantoin; and step (3) in which the 5-(β-methylmercaptoethyl)hydantoin obtained in step (2) is hydrolyzed in the presence of a basic potassium compound to give methionine. | 2010-05-13 |
20100121105 | Composition and Method of synthesizing a biomolecule and its therapeutics applications - It is disclosed a method which relates to the ex-vivo of synthesizing J-Factor and its therapeutic application. In-vivo mechanism involves the secretion of Growth Hormone (GH), and its binding to the GH receptor. During enzymatic interaction between GH and the receptor, at least one of its amino acid specifically L-arginine is changed to J-factor by the bond shifting action in the guanidino group of L-arginine. Finally the GH is broken down into its respective amino acid units within the cell, and the J-Factor starts to accumulate gradually. Thus accumulated J-factor stimulates the synthesis and secretion of autocrine-paracrine IGF-1. IGF-I induces changes in the cell which prevent aging signs. The method further relates to ex-vivo synthesis of J-factor which is responsible for the changes in the cell and its administration to humans and animal. In one of the preferred embodiment the ex-vivo synthesized J-factor is administrated to the patients and the changes in the patients was observed. | 2010-05-13 |
20100121106 | Method for preparing carbonylic perfluoropolyethers - A process for preparing perfluoropolyethers of formula | 2010-05-13 |
20100121107 | CRYSTAL STRUCTURE OF BIFUNCTIONAL TRANSGLYCOSYLASE PBP1B FROM E. COLI AND INHIBITORS THEREOF - The crystal structure at 2.16 Å resolution of the full-length bacterial bifunctional transglycosylase penicillin-binding protein 1b (PBP1b) from | 2010-05-13 |
20100121108 | PROCESS FOR SYNTHESIZING DESVENLAFAXINE FREE BASE AND SALTS OR SOLVATES THEREOF - The invention relates generally to an improved process for manufacturing desvenlafaxine free base and salts or solvates thereof. | 2010-05-13 |
20100121109 | METHOD FOR PRODUCING ETHYLENEAMINES FROM UNTREATED AAN - The invention relates to a process for preparing an ethylene amine mixture, which comprises the following steps:
| 2010-05-13 |
20100121110 | METHOD FOR THE BREAKDOWN OF LIGNIN - The invention describes a method for the direct production of molecules with a minimum molecular weight of 78 g/mol by the breakdown of lignin, lignin derivatives, lignin fragments, and/or lignin-containing substances or mixtures in the presence of at least one polyoxometallate and preferably in the presence of a radical scavenger in a liquid medium. | 2010-05-13 |
20100121111 | Alkoxylations of High Melting Point Substrates in Ketone Solvents - Substrate or starting compounds which have high melting points, for instance, having a melting point of 150° C. or higher and having at least one active hydrogen may be reacted with one or more alkylene oxide in a ketone solvent at reduced temperatures compared with conventional, molten methods to give an adduct product having reduced color. By at least partially alkoxylating the substrate, its potential for crystallization is disrupted and the partially alkoxylated substrate has a lower melting point than the original substrate permitting it to be more readily further alkoxylated at the reaction temperature. Suitable ketone solvents include, but are not necessarily limited to, methyl isobutyl ketone, diethyl ketone, methyl ethyl ketone, and mixtures thereof. The alkoxylation reaction may be conducted at a temperature in the range of about 30 to about 140° C. Suitable catalysts may include tertiary amines or caustic compounds such as NaOH and KOH. | 2010-05-13 |
20100121112 | Method for the purification of carotenoids from plant extracts and the products so obtained - A novel process for the preparation of highly purified carotenoids from plant extracts, especially the marigold flower extracts, is disclosed. The process includes the formation, isolation and purification of carotenoids, primarily lutein and zeaxanthin, at lower temperatures with the use of at least a polar solvent and at least a non-polar solvent. The highly purified carotenoids so obtained are useful for human consumption, such as nutritional supplements and pharmaceuticals. | 2010-05-13 |
20100121113 | PROCESS FOR PRODUCING LOW COLOR GLYCOLS - The present invention provides a process for producing low color glycols that comprises altering at least one condition of a reaction component and/or process stream within the process to be unfavorable for the formation of at least one color-producing contaminant intermediate. As such, such intermediates may be reduced in concentration, or even eliminated entirely, from glycols produced by the process. Since they are not present, or are present in reduced number, the intermediates cannot form color-producing contaminants in the glycols, and low color glycols are provided to the customer. Any condition that can discourage the formation of color forming contaminant intermediates can be adjusted, although conditions that can be adjusted by materials or equipment already utilized in the process, e.g., temperature, pressure, pH, concentration of a color-forming contaminant precursor, the presence of one or more solvents or catalysts favorable for the production of the color-producing contaminant or contaminant intermediate, and the like, are preferred. | 2010-05-13 |
20100121114 | Tunable catalyst gas phase hydrogenation of carboxylic acids - A process for selective formation of ethanol from acetic acid includes contacting a feed stream containing acetic acid and hydrogen at an elevated temperature with catalyst comprising platinum and tin on a high surface area silica promoted with calcium metasilicate. Selectivities to ethanol of over 85% are achieved at 280° C. with catalyst life in the hundreds of hours. | 2010-05-13 |
20100121115 | DEHYDROFLUORINATION PROCESS TO MANUFACTURE HYDROFLUOROOLEFINS - Disclosed is a process for the manufacture of hydrofluoroolefins of the structure CF | 2010-05-13 |
20100121116 | PROCESS FOR PREPARING OCTAFLUOROCYCLOHEXADIENE - Disclosed herein is a process of preparing octafluorocyclohexadiene using hexafluorobenzene as a raw material. The hexafluorobenzene reacts with an activated fluorinating agent at 60-200° C. in an inert gas atmosphere. The activated fluorinating agent is prepared by mixing 1-10 wt % of cobalt difluoride with 90-99 wt % of other metal fluoride selected from the group of calcium fluoride, magnesium fluoride, aluminum fluoride, sodium fluoride and potassium fluoride. The mixture reacts with fluorine gas at 200-400° C. | 2010-05-13 |
20100121117 | PROCESS FOR PREPARING DECAFLUOROCYCLOHEXENE - Disclosed herein is a process of preparing decafluorocyclohexene using hexafluorobenzene as a raw material. The hexafluorobenzene reacts with an activated fluorinating agent at 60-200° C. in an inert gas atmosphere. The activated fluorinating agent is prepared by mixing 1-50 wt % of cobalt difluoride with 50-99 wt % of other metal fluoride selected from calcium fluoride, magnesium fluoride, aluminum fluoride, sodium fluoride and potassium fluoride. The mixture reacts with fluorine gas at 200-400° C. | 2010-05-13 |
20100121118 | PROCESS FOR PRODUCING FLUORINE-CONTAINING COMPOUND - The process for producing a fluorine-containing compound such as 1,2,3,4-tetrachclorohexafluorobutane of the present invention is characterized in that a halogenated hydrocarbon compound such as 1,2,3,4-tetrachlorobutane is brought into contact with fluorine gas in a liquid phase or in a solid-liquid coexistence state in the absence of a solvent and a catalyst. According to the present invention, a fluorine-containing compound is readily produced from a halogenated hydrocarbon compound using neither a reaction solvent nor a reaction catalyst. | 2010-05-13 |
20100121119 | Hydrocarbon Conversion Process Improvements - Improvements in previously disclosed methods of and apparatuses for converting alkanes, alkenes, and aromatics to olefins, alcohols, ethers, and aldehydes includes: safety improvements, use of alternative feedstocks, process simplification, improvements to the halogenation step, improvements to the reproportionation step, improvements to the solid oxide reaction, improvements to solid oxide regeneration, improvements in separations, maintenance, start-up, shut-down, and materials of construction. | 2010-05-13 |
20100121120 | PROCESS FOR UPGRADING HYDROCARBONS - A process for upgrading hydrocarbons comprising removal of C5 hydrocarbons from a feedstock, metathesizing said C5 hydrocarbons to C6+ and C4− hydrocarbons, and upgrading said C4− hydrocarbons is disclosed. | 2010-05-13 |
20100121121 | CONTINUOUSLY CRACKING TECHNOLOGY OF WASTE RUBBER OR PLASTICS AND ITS EQUIPMENT - This invention is about a continuously cracking technology of waste rubber or plastics and its realizing equipment, which is the key technology to produce oil by use of waste rubber or plastics. The cracking process is as following: the catalyst and rubber or plastics are extruded and transported in order to separate the air or to prevent oxidization; the raw materials are transported into the cracking chamber and moved from the inlet orifice to the discharge hole; the cracking process of the raw material is finished; and finally the products are deviated automatically through the discharge hole. In this invention, the separation of air and oxygen in the inlet orifice and discharge hole of the cracking chamber can completely avoid the hidden dangers caused by incoming of oxygen into the cracking chamber, and thus realize industrial production with continuous feedings. Moreover, the ratio of the oil can be raised from 19% in current technology to 45%-48%, and the loss of production equipment can be reduced. Therefore, production cost will become lower, safety measurement will become better and highly effective and continuous production will really come true. | 2010-05-13 |
20100121122 | HYDROCARBON CONVERSION USING MOLECULAR SIEVE SSZ-75 - The present invention relates to new crystalline molecular sieve SSZ-75 prepared using a tetramethylene-1,4-bis-(N-methylpyrrolidinium) dication as a structure-directing agent, and its use in catalysts for hydrocarbon conversion reactions. | 2010-05-13 |
20100121123 | ZINC FERRITE CATALYSTS, METHOD OF PREPARING THEREOF AND METHOD OF PREPARING 1,3-BUTADIENE USING THEREOF - The present invention relates to a zinc ferrite catalyst, a method of producing the same, and a method of preparing 1,3-butadiene using the same. Specifically, the present invention relates to a zinc ferrite catalyst which is produced in a pH-adjusted solution using a coprecipitation method, a method of producing the same, and a method of preparing 1,3-butadiene using the same, in which the 1,3-butadiene can be prepared directly using a C4 mixture including n-butene and n-butane through an oxidative dehydrogenation reaction. The present invention is advantageous in that 1,3-butadiene can be obtained at a high yield directly using a C4 fraction without performing an additional process for separating n-butene, as a reactant, from a C4 fraction containing impurities. | 2010-05-13 |
20100121124 | HYDROCARBON CONVERSION USING MOLECULAR SIEVE SSZ-75 - The present invention relates to new crystalline molecular sieve SSZ-75 prepared using a tetramethylene-1,4-bis-(N-methylpyrrolidinium) dication as a structure-directing agent, and its use in catalysts for hydrocarbon conversion reactions. | 2010-05-13 |
20100121125 | Char Methanation Catalyst and its Use in Gasification Processes - The invention provides processes for generating a methane-enriched gas from a gas mixture comprising carbon monoxide and hydrogen such as gas streams generated by gasification of an alkali metal catalyst-loaded carbonaceous feedstock, and a char methanation catalyst useful in such processes. | 2010-05-13 |
20100121126 | Process For Purification of Hydrocarbons - The present invention relates to a process for the removal of sulfur contaminants from a hydrocarbon stream comprising: (a) providing a gaseous hydrocarbon stream having sulfur contaminants, but having less than 10 ppmw of said sulfur contaminants as thiophenes, to a bed of adsorbent material, said material having at least one Group VIII metal compound with at least one Group VI, IA, IIA, IB metal compound on an inorganic metal oxide support material, without substantial added hydrogen, to absorb said contaminants; (b) periodically stopping said providing of said gaseous hydrocarbon feed stream of (a); (c) then, regenerating said adsorbent bed by introducing at least one regenerant, in any order, in the place of said stream; and, (d) continuing to alternate (a) and (b) plus (c) as needed. | 2010-05-13 |
20100121127 | METHOD FOR MANUFACTURING A METALLIC HYDROXIDE AND OXIDE POWDER WHICH IS SELF-DISPERSING IN WATER, POWDER AND AQUEOUS DISPERSION OBTAINED, USES THEREOF - The invention resides in a method for manufacturing a metallic hydroxide-based and metallic oxide-based powder, which is self-dispersing in water, characterized in that a metallic oxide powder is partially treated with a polymer in the form of an aqueous emulsion and/or solution, in such a way that the level of metallic hydroxide by dry weight within said treated powder is less than 99% of its total weight, and in that said polymer is a water-soluble homopolymer or copolymer containing at least one vinylic monomer. In one particular variant, the polymer is a water-soluble copolymer containing a vinylic monomer and a non-ionic monomer, and the metal is calcium and/or magnesium. The invention also pertains to the powders obtained, their uses in aqueous suspensions, in treating waste, as a chemical additive, or as a soil amendment. | 2010-05-13 |
20100121128 | Method and apparatus for thermochemical conversion of materials - A system for treating carbon-containing or silicon-containing end-of-life material includes a reactor | 2010-05-13 |
20100121129 | EXPANDABLE BRACHYTHERAPY DEVICE - A brachytherapy device including an elongate member comprising a proximal portion and a distal portion. The device also includes a movable surface portion surrounding at least the distal portion of the elongate member and a plurality of source lumen tubes defining respective source lumens, the source lumen tubes being located around the elongate member, distal ends of the source lumen tubes coupled to the distal portion of the elongate member, the source lumen tubes extending a sufficient distance in a proximal direction such that the source lumen tubes extend outside a body when distal portions of the source lumen tubes are positioned in a body cavity for brachytherapy. The device also has structure coupled to the distal ends of the source lumen tubes for positioning the distal portions of the source lumen tubes at different distances from the elongate member for brachytherapy by exerting a force in a proximal direction on the distal ends of the source lumen tubes, the structure including an actuator for actuating the structure, at least a portion of the actuator being located outside the body when the distal portions of the source lumen tubes are positioned in a body cavity for brachytherapy. The device also includes a ring, tube or manifold securing a portion of the source lumen tubes proximal to the distal portion around the elongate member and a source of radiation suitable for insertion into the source lumens. | 2010-05-13 |
20100121130 | DELIVERY SYSTEM AND METHOD FOR INTERSTITIAL RADIATION THERAPY - A prescription method of treating tissue comprises the steps of accepting a prescription tissue treatment plan for the tissue to be treated, positioning seeds relative to each other per the prescription tissue treatment plan such that the positions of seeds relative to each other is only established by the prescription tissue treatment plan, and creating a treatment strand by heating and cooling a material to position the plurality of treatment seeds in the material. The prescription tissue treatment plan specifies a number and a spacing of the seeds to be provided in the treatment strand, the spacing of the treatment seeds being unrestricted by any use of spacers and independently set by and according to the prescription tissue treatment plan. | 2010-05-13 |
20100121131 | APPARATUS AND METHODS FOR STIMULATING A BODY'S NATURAL HEALING MECHANISMS - Devices, systems, and methods for inducing biologic effects in living tissue to affect the growth, repair, and maintenance behavior of the living tissue, said biologic effects induced by proximity to and exposure to light, electromagnetic, and sound energies selected according to desired responses and operated at parameters including selectable time periods, intensities, and pulse frequencies. | 2010-05-13 |
20100121132 | CARDIAC DEVICE AND METHODS OF USE THEREOF - Devices and methods are described herein which are directed to the treatment of a patient's heart having, or one which is susceptible to heart failure, to improve diastolic function. | 2010-05-13 |
20100121133 | Apparatus and methods for measuring pressure and flow in cardiac assist devices and peripheral vasculature - Disclosed are apparatus and methods for measuring pressure and/or flow in blood circulatory systems of a patient using cardiac assist devices. By way of example, a left ventricular assist device may be coupled between the left ventricle of the patient's heart and the aorta. One or more sensors, such as pressure sensors, are located at one or more selected locations in the heart, in blood-carrying conduits that are coupled to the cardiac assist device, or in the aorta, that sense pressure, for example, to monitor a patient's cardiac function. A monitoring device is coupled to the sensors that implements an algorithm that determines pressure and/or blood flow rate in the circulatory system using pressures and/or flow data derived from the sensors. | 2010-05-13 |
20100121134 | BONE CONDUCTION DEVICES GENERATING TANGENTIALLY-DIRECTED MECHANICAL FORCE USING A ROTATIONALLY MOVING MASS - A bone conduction device, comprising: a sound input element configured to receive an acoustic sound signal; an electronics module configured generate an electrical signal representing said acoustic sound signal; and a transducer, comprising a mass configured to move in a rotational direction, configured to generate a vibrational force in a tangential direction with respect to a recipient's bone. | 2010-05-13 |
20100121136 | Methods and apparatus for capturing and manipulating body parts - A device for grasping a body part is preferably a catheter having a proximal end and distal end, the proximal end being juxtaposed a user while in use. A grasping section is attached to the catheter near or at the distal end. The grasping section has a first position wherein a body part may be received by the grasping section and a second position wherein the grasping section grasps the body part with sufficient force to enable the operator to move the body part to a desired location. | 2010-05-13 |
20100121138 | APPARATUS AND METHOD FOR SENSING FORCE - A medical system comprises a medical probe including an elongated probe body, a lumen extending within the probe body, an axially flexible section, and a push-pull rod slidably disposed within the lumen. The system comprises a ditherer mechanically coupled to the rod for cyclically displacing it axially back and forth within the lumen, such that the ends of the probe body are axially displaced relative to each other via the axially flexible section. The system further comprises a sensor for sensing a force axially applied to the distal end of the probe body. A method comprises introducing a medical probe into a patient, axially dithering the distal end of the medical probe back and forth relative to the proximal end of the medical probe, and sensing a force applied between tissue of the patient and the distal end of the medical probe while the distal end is axially dithered. | 2010-05-13 |
20100121139 | Minimally Invasive Imaging Systems - Aspects of the invention include minimally invasive imaging system. Systems according to embodiments of the invention include: an access device having a proximal end and distal end and an internal passageway extending from the proximal to distal end; and an elongated member dimensioned to be slidably moved through the internal passageway of the access device and having a proximal and distal end. In the systems of the invention, at least one of multiple visualization elements and multiple illumination elements are positioned among the distal ends of the access device and the elongated member. Also provided are methods of using the systems in imaging applications, as well as kits for performing the methods. | 2010-05-13 |
20100121140 | ENDOSCOPE ENDCAP FOR SUTURING TISSUE - Medical systems, devices and methods are disclosed for suturing a perforation in tissue, that may be employed endoscopically and/or laparoscopically, and that offer simple, reliable and controllable placement of suture around a perforation for complete closure thereof. One embodiment of the medical device generally includes an endcap for use with an endoscope to suture an opening in tissue using a tissue anchor. The endcap has a tubular shape defined by an annular sidewall, and the sidewall defines an interior space. A side port is further defined by the annular sidewall and is in communication with the interior space. The side port is sized to receive and locate the tissue within the interior space for suturing. A support rib is positioned within the interior space and distal to the side port. The support rib and sidewall define a piercing aperture therebetween that supports the tissue being sutured. | 2010-05-13 |
20100121141 | ENDOSCOPIC CUTTING AND DEBRIDING DEVICE MOUNTED ON A FLEXIBLE AND MANEUVERABLE TUBE EMPLOYING A FLUID-DRIVEN TURBINE - An endoscope for visualizing and operating upon a surgical site within a human body employs an elongated tubular body adapted to be inserted through bodily passages so that the distal end is adjacent the surgical site. The body has a flexible section, at least proximal to the distal end, and manually adjustable bending controls at the proximal end may be manipulated to impose bending forces on the distal end to steer the distal end to the surgical site. A fluid turbine supported for rotation adjacent the distal end is powered by fluids pumped through a passage so as to rotate the turbine. The various cutters and debriding tools may be attached to the distal ends so that they are rotated by the turbine. | 2010-05-13 |
20100121142 | Minimally Invasive Imaging Device - Aspects of the invention include minimally invasive internal target tissue site imaging devices. Devices according to embodiments of the invention include an elongate member dimensioned to access an internal target tissue location, e.g., an intervertebral disc, and having a proximal end and a distal end; a white light source at the distal end; a near-infra-red light source the distal end; and an imaging sensor at the distal end. Also provided are methods of using the systems in imaging applications, as well as kits for performing the methods. | 2010-05-13 |
20100121143 | ENDOSCOPE APPARATUS AND SCANNING ENDOSCOPE PROCESSOR - An endoscope apparatus, comprising an imaging controller, a receiver, and an image generator, is provided. The imaging controller makes an optical image to be captured so that the amount of optical information to be captured per a certain area size for an enlarged observation area is greater than that for a normal observation area. The receiver receives the optical information as a pixel signal. The image generator generates a normal image signal corresponding to a normal image on the basis of the pixel signals captured within the normal observation area and a part of the pixel signals captured within the enlarged observation area. The image generator generates an enlarged image signal corresponding to an enlarged image on the basis of the pixel signals captured within the enlarged observation area. | 2010-05-13 |
20100121144 | Endoscope Accessory - This invention relates generally to an endoscope accessory. This device uses an overtube with an inflatable positioning balloon that can be inflated after placement of the overtube just proximal to the tip of the endoscope or echoendoscope. This balloon creates a temporary blockade of the gastrointestinal tract proximal to the portion that needs to be examined. The other part of the device is a catheter with an occlusion balloon affixed to its free endportion and can be passed through a passageway within the overtube and extended beyond the tip of the endoscope, distal to the part of the gastrointestinal tract that needs to be examined. Inflation of this balloon together with positioning balloon creates a closed space within the body cavity that can be filled with air or water for improving the quality of the examination with regular endoscope of echoendoscope, respectively, while reducing the examination complications. | 2010-05-13 |
20100121145 | METHOD AND SYSTEM FOR MEASURING INSERTED LENGTH OF A MEDICAL DEVICE USING INTERNAL REFERENCED SENSORS - Measured locations of position sensors on a steerable medical device are used to determine the insertion depth of the steerable medical device with respect to a foundation point, which is initialized by an operator. The insertion depth, in turn, is used to determine the state of each segment that has passed the foundation point, i.e., is distal to the foundation point. | 2010-05-13 |
20100121146 | SCANNING ENDOSCOPE, SCANNING ENDOSCOPE PROCESSOR, AND SCANNING ENDOSCOPE APPARATUS - A scanning endoscope comprising a first transmitter, an actuator, a first mirror, and a second mirror, is provided. The first transmitter emits a beam of radiant light from an emission end. The actuator moves the emission end along a spiral course. The first mirror is arranged from the emission end toward a first direction. The first mirror comprises a first reflection surface around the first direction. The first reflection surface reflects the radiant light emitted from the first transmitter. The second mirror is arranged around the first reflection surface. The second mirror comprises a second reflection surface. The second reflection surface reflects the radiant light reflected by the first mirror in a direction that includes the first direction as a positive vector toward any points on the first line. | 2010-05-13 |
20100121147 | STEERING MECHANISM - A steering mechanism is used as part of a medical device such as a catheter or an endoscope to allow movement of a steerable distal portion of the catheter or endoscope. The mechanism can include a elongate housing and an actuation system. The elongate housing is adapted to be coupled to the steerable portion of the medical device. The actuation system includes an actuator, a first cam, and a second cam. The actuator can move the first cam between a first position and a second position as the actuator is moved along a first axis (or about a second axis different than the first axis). Movement of the first cam between its first and second positions moves the steerable portion of the medical device along a first plane. The actuator can move the second cam between a first position and a second position as the actuator is moved along the second axis (or about the first axis). Movement of the second cam between its first and second positions moves the steerable portion of the medical device along a second plane different than the first plane. | 2010-05-13 |
20100121148 | METHOD AND SYSTEM FOR STEERABLE MEDICAL DEVICE PATH DEFINITION AND FOLLOWING DURING INSERTION AND RETRACTION - Waypoints for a steerable medical device are stored as the steerable medical device is moved within a patient. The stored waypoints are an ordered sequence of locations. The ordered sequence of locations defines a safe path within the patient for moving an articulatable portion of the steerable medical device. The articulatable portion of the steerable medical device is constrained to follow the safe path as the articulatable portion moves within the patient. For example, the articulatable portion of the steerable medical device is constrained to remain within a boundary region enclosing the safe path as the articulatable portion of the steerable medical device follows the safe path. | 2010-05-13 |
20100121149 | INTERFACE BETWEEN A SURGEON AND AN AUTOMATED ASSISTANT AND METHOD THEREOF - An interface between a surgeon and an automated assistant, including: at least one array comprising N RF transmitters, where N is a positive integer; at least one RF receiver provided with at least two directional antenna; means for attaching said RF transmitter array to at least one surgical tool; and a computerized operating system adapted to record the received signal strength (RSS) received by each antenna of the one RF receiver and to calculate therefrom the position of each of the N RF transmitters, and further adapted to provide automatically the results of the calculation to the surgeon. | 2010-05-13 |
20100121150 | CAPSULE MEDICAL APPARATUS AND CURRENT-CARRYING CONTROL METHOD - An object of the present invention is to readily initiate an operation of a capsule medical apparatus which is inserted into a subject and executes a predetermined function. In a capsule endoscope | 2010-05-13 |
20100121151 | METHOD AND SYSTEM FOR STEERABLE MEDICAL DEVICE PATH DEFINITION AND FOLLOWING DURING INSERTION AND RETRACTION - Waypoints for a steerable medical device are stored as the steerable medical device is moved within a patient. The stored waypoints are an ordered sequence of locations. The ordered sequence of locations defines a safe path within the patient for moving an articulatable portion of the steerable medical device. The articulatable portion of the steerable medical device is constrained to follow the safe path as the articulatable portion moves within the patient. For example, the articulatable portion of the steerable medical device is constrained to remain within a boundary region enclosing the safe path as the articulatable portion of the steerable medical device follows the safe path. | 2010-05-13 |
20100121152 | SUCTION CATHETER ASSEMBLY FOR A LARYNGOSCOPE - A laryngoscope is provided with a suction catheter assembly that includes a catheter to supply suction for removal of fluids (e.g., blood, vomit, secretions, and so on) proximate to the distal end of the blade of the laryngoscope during intubation. A connector secures the catheter to the distal end of the blade. A retainer holds the catheter against the side of the blade. | 2010-05-13 |
20100121153 | RETRACTOR CANNULA SYSTEM FOR ACCESSING AND VISUALIZING SPINE AND RELATED METHODS - Retractor cannula systems may be used for accessing and visualizing the spine and related methods of treatment, including a forward-looking retractor cannula system for creating a working space and the retractor cannula system having atraumatic dissection capability to allow visualization in spine. The devices and methods described may be used, for example, to perform annulus repair, herniated disc excision, and denervation of neurological tissue; to dispense pharmacological agents and/or cell or tissue therapy agents; to diagnose disc degeneration and bony degeneration, spinal stenosis, and nucleus decompression, and to perform disc augmentation. | 2010-05-13 |
20100121154 | METHOD AND APPARATUS FOR ELECTRONIC ADJUSTMENT OF ILLUMINANCE OF SURGICAL LAMP - The present invention provides a surgical lamp for illuminating a surgical site. The surgical lamp includes a housing that defines an internal cavity. A light source is disposed within the internal cavity of the housing for producing a light field at a surgical site that is remote from the housing. A voltage sensitive device is disposed between the light source and the surgical site. The voltage sensitive device has light transmissive properties that change in response to a biasing voltage applied thereto. Control means control the biasing voltage to the voltage sensitive device. | 2010-05-13 |
20100121155 | Minimally Invasive Tissue Modification Systems With Integrated Visualization - Aspects of the invention include minimally invasive tissue modification systems. Embodiments of the systems include a minimally invasive access device having a proximal end, a distal end and an internal passageway. Also part of the system is an elongated tissue modification device having a proximal end and a distal end. The tissue modification device is dimensioned to be slidably moved through the internal passageway of the access device. The tissue modification device includes a tissue modifier. Positioned among the distal ends of the devices are a visualization element and an illumination element. Also provided are methods of using the systems in tissue modification applications, as well as kits for practicing the methods of the invention. | 2010-05-13 |
20100121156 | REMOTE-MEDICAL-DIAGNOSIS SYSTEM METHOD - Provided are a remote medical-diagnosis system including: a bio-disc or a biochip performing biological, chemical or biochemical reactions with a sample, and having a barcode or a RF IC; a bioanalytical device analyzing results of reactions performed by the bio-disc or the biochip and including a reader reading the barcode or the RF IC to authenticate the bio-disc or the biochip or recording the measured data to the RF IC regardless of a connection with a remote diagnosis server; a virtual doctor as a software in a user's terminal, the virtual doctor providing a user with guidelines and instructions as how to use the bioanalytical device, and providing the user with a consulting service, a diagnosis unit self-analyzing the measured data using mathematical calculations and outputing results of a diagnosis; a user's terminal providing the user with a consulting service from a medical expert or a virtual doctor; a medical expert's terminal providing the user with a consulting service; and a remote diagnosis server connecting the user with the medical expert during periodic medical consultations, connecting the user with the virtual doctor during non-periodic medical consultations, blocking connection between the user and the virtual doctor if a periodic medical consultations term has elapsed; and a method of performing the remote medical-diagnosis. | 2010-05-13 |
20100121157 | WIRELESS SENSOR RESIDENT ANNOTATIONS - A high percentage of preventable medical errors occur due to poor communication during the period when patient care is handed from one caregiver to another. Electronic annotations from patient specific body sensor networks are created and classified according to the caregiver and the urgency of the annotation to ensure that no information goes unnoticed during the transfer of care. Sensors ( | 2010-05-13 |
20100121158 | Physiologically Modulated Visual Entrainment Device - A device comprised of one component that emits pulsing light patterns across the entire human visual field and a second component that monitors physiological activity and regulates the first component. The device is composed of glasses with dense light array emitting sources across the entire visual field of both eyes. This array may emit any of the possible combinations and permutations from the domains of (but not limited to), wave frequency, intensity, color, coherence, phase and type including sinusoidal, square, or saw tooth waves. By driving these possible combinations, different areas of the brain can be stimulated. Since various areas of the brain control CNS (Central Nervous System) functions, the secondary CNS monitoring component can be coupled with these various brain regions to enhance response to training. The data that the device detectors collect will provide recommendations for natural and pharmaceutical agents to enhance the function of the device. | 2010-05-13 |
20100121159 | Devices and Methods for Monitoring Core Temperature and an Intraperitoneal Parameter - Methods and apparatus for monitoring core temperature of a patient receiving intraperitoneal hypothermia or hyperthermia are provided which may include any number of features. One feature is placing a monitoring device having a sensor into a non-intraperitoneal cavity of a patient. The non-intraperitoneal cavity can be a urethra, a rectum, an anal sphincter, a stomach, an esophagus, the peripheral vasculature, or a vagina, for example. Another feature is sensing core temperature of the patient with the sensor. | 2010-05-13 |
20100121160 | REMOTE PSYCHOLOGICAL EVALUATION - Instrumented orthoses with more sophisticated structures provide for coordinated support and rehabilitation of complex joints and multiple injured joints. Improved instrumented orthoses can include hinges that can rotate in multiple different planes. Particularly preferred embodiments include a shoulder brace with a hand hold and a lower extremities brace. Preferably, a control unit monitors the output Of transducers used to instrument the brace. A patient can be prompted by the control unit for the performance of a variety of different monitored exercises. | 2010-05-13 |
20100121161 | Ambulatory Urodynamics - An ambulatory urodynamic data gathering system includes one or more sensors disposed in the gastrointestinal tract, a sensor disposed in the bladder, a sensor disposed at the entrance to the urethra, and a data recorder worn by the patient that is disposed around the patient's waist. The sensors transmit data to the recorder unit, which stores the received data for subsequent analysis. The recorder unit also activates the various sensors as necessary to obtain information at certain predetermined intervals to limit battery usage. The recorder unit can also interrogate the various sensors to obtain the information. In one exemplary embodiment, the ambulatory urodynamic data gathering system includes a method and device for simultaneously recording radio transmitted pressure measurements from a swallowed self-contained capsule (pressure monitor, signal processing, transmitter, power source or coupling antenna), and a self-contained unit placed in the bladder, for the purpose of deriving urodynamic information. The system of the present invention enables collection of pressure wave information above the waist of the patient so that a doctor can subsequently analyze the data to determine where the problem may lie. | 2010-05-13 |
20100121162 | CHILD-FRIENDLY ANALYTE MEASUREMENT INSTRUMENT - Embodiments of a child-friendly analyte measurement system are provided for detecting at least one analyte in a bodily fluid. A measurement system comprises at least one measurement instrument for detecting the analyte in the bodily fluid, such as a commercially available measurement instrument. The measurement instrument is configured as a portable hand-held instrument and has a housing with at least one display element. Furthermore, the measurement system comprises a toy, in particular a figurine or a toy animal. The toy has at least one receptacle for reversibly holding the measurement instrument, which receptacle is configured such that if the measurement instrument is held by the receptacle, the display element is accessible, at least in part. The measurement instrument is configured such that it can be used both in the measurement system and also, optionally, independently of the toy. Further aspects include a kit, a method, and the toy for the provided measurement system. | 2010-05-13 |
20100121163 | Optical Microneedle-Based Spectrometer - Optical microneedles are adapted for near-infrared or mid-infrared in vivo spectroscopic sensing; and provide a MEMS-based spectrometer for continuous lactate and glucose monitoring by means of a near-infrared or mid-infrared optical microneedle array in a transdermal patch. | 2010-05-13 |
20100121164 | Oximeter device - An oximeter has a housing configured to have a cavity defining portion that is adapted to be fitted with covers of various dimensions to effect receptacles of different dimensions for accommodating differently sized sensor of sensor assemblies that are matable to the oximeter for sensing physical attributes of a patient. Each of the covers, once fully fitted to the housing, is fixedly latched thereto unless a force that overcomes the latching is applied to remove the cover. The effected receptacle is adapted to biasedly retain a corresponding sensor placed therein. The holstered sensor therefore would not accidentally fall out or be removed from the receptacle, until the user deliberately applies a force to remove the sensor from the receptacle. | 2010-05-13 |
20100121165 | Subcutaneous Glucose Electrode - A small diameter flexible electrode designed for subcutaneous in vivo amperometric monitoring of glucose is described. The electrode is designed to allow “one-point” in vivo calibration, i.e., to have zero output current at zero glucose concentration, even in the presence of other electroreactive species of serum or blood. The electrode is preferably three or four-layered, with the layers serially deposited within a recess upon the tip of a polyamide insulated gold wire. A first glucose concentration-to-current transducing layer is overcoated with an electrically insulating and glucose flux limiting layer (second layer) on which, optionally, an immobilized interference-eliminating horseradish peroxidase based film is deposited (third layer). An outer (fourth) layer is biocompatible. | 2010-05-13 |
20100121166 | Subcutaneous Glucose Electrode - A small diameter flexible electrode designed for subcutaneous in vivo amperometric monitoring of glucose is described. The electrode is designed to allow “one-point” in vivo calibration, i.e., to have zero output current at zero glucose concentration, even in the presence of other electroreactive species of serum or blood. The electrode is preferably three or four-layered, with the layers serially deposited within a recess upon the tip of a polyamide insulated gold wire. A first glucose concentration-to-current transducing layer is overcoated with an electrically insulating and glucose flux limiting layer (second layer) on which, optionally, an immobilized interference-eliminating horseradish peroxidase based film is deposited (third layer). An outer (fourth) layer is biocompatible. | 2010-05-13 |
20100121167 | Alarm Characterization for Analyte Monitoring Devices and Systems - Methods and apparatus including determining a rate of occurrence of a glycemic excursion event, determining a frequency of an alarm activation associated with the glycemic excursion event, determining an analyte level associated with the alarm activation, and setting an alarm parameter based on one or more of the determined rate of occurrence of the glycemic excursion event, the frequency of the alarm activation associated with the glycemic excursion event or the determined analyte level are provided. | 2010-05-13 |
20100121168 | Method and System for Transferring Analyte Test Data - A system for transferring data includes an analyte test instrument (ATI) adapted to store data, a wirelessly enabled data management device (DMD) for comprehensively analyzing data, and an adaptor removably connected to the ATI for transferring data stored on the ATI to the DMD. The adaptor includes a data communication device capable of removable connection with the ATI, a microprocessor electrically connected to the data communication device, a wireless controller electrically connected to the microprocessor and a wireless transceiver electrically connected to the wireless controller. In use, data transfer is executed between the ATI and the DMD by electrically and mechanically connecting the adaptor to the ATI. Data stored on the ATI is then automatically downloaded into adaptor memory. Upon completion of the download, the user activates an externally accessible input device on the adaptor which, in turn, wirelessly transmits data from the adaptor memory to the DMD. | 2010-05-13 |
20100121169 | CELLULOSIC-BASED INTERFERENCE DOMAIN FOR AN ANALYTE SENSOR - The present invention relates generally to devices for measuring an analyte in a host. More particularly, the present invention relates to devices for measurement of glucose in a host that incorporate a cellulosic-based interference domain. | 2010-05-13 |
20100121170 | FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL - Disclosed are methods and apparatuses for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment dose (e.g. insulin, dextrose, etc.) and provide glycemic control. The dose of the treatment drug may be based on the patient's calculated sensitivity to treatment dosing, for example. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte. Delivery of the treatment drug can be cut off if the determined analyte concentration indicates that continued delivery would be harmful to the patient. | 2010-05-13 |
20100121171 | METHOD OF MEASURING BLEEDING VOLUME - A method of measuring blood clotting ability of a patient. A known volume of blood is dispensed on a reference disc of blotter paper, such that at least one reference blotch is formed on the reference disc. The surface area of the reference blotch formed on the reference disc, such that a relationship between the volume of blood and the surface area of the reference blotch can be obtained. An incision is made at the patient. A piece of blotter paper to the incision is applied to the incision to collect blood flowing therefrom, such that at least one blotch is formed on the piece of blotter paper. The surface area of the blotch formed on the piece of blotter paper is measured. The volume of the blood absorbed blood by the blotter paper is calculated according to the relationship between the blood volume and the surface area of the blotch. | 2010-05-13 |
20100121172 | MICROSCOPIC AND MACROSCOPIC DATA FUSION FOR BIOMEDICAL IMAGING - Macroscopic imaging data, such as CT, MR, PET, or SPECT, is obtained. Microscopic imaging data of at least a portion of the same tissue is obtained. The microscopic imaging data is spatially aligned with the macroscopic imaging data. The spatial alignment allows calculation and/or imaging using both types of data as a multi-resolution data set. A given image may include information about the relative position of the microscopically imaged tissue to the macroscopically imaged body portion. This positional relationship may allow viewing of affects or changes at cellular levels as well as less detailed tissue structure or organism levels and may allow determination of any correlation between changes in both levels. | 2010-05-13 |
20100121173 | ELECTRICAL SYSTEMS FOR DETECTION AND CHARACTERIZATION OF ABNORMAL TISSUE AND CELLS - An apparatus for the diagnosis of a biological sample is disclosed. An embodiments of the apparatus includes a probe, a probe head distally connectable to the probe, the probe head further comprising a plurality of electrode elements thereby forming an electrode array where each electrode element is variably actuatable to apply an electrical signal to the biological sample; an RF signal source for applying the electrical signal to the electrode array; an electrode selector adapted and configured to switch the electrical signal from the RF signal source between the plurality of electrode elements; and a detection circuit for analyzing a dielectric property received from the biological sample. Methods and kits for diagnosing a biological sample are also disclosed. | 2010-05-13 |
20100121174 | PROBE VISUALIZATION BASED ON MECHANICAL PROPERTIES - A method for visualization includes receiving an input indicative of respective apparent coordinates of a plurality of points disposed along a length of a probe inside a body of a subject, and applying a model of known mechanical properties of the probe to the apparent coordinates so as to compute a cost function with respect to shapes that can be assumed by the probe in the body. A shape is chosen responsively to the cost function, and corrected coordinates of the points along the length of the probe are generated based on the shape. The representation of the probe using the corrected coordinates is then displayed. | 2010-05-13 |
20100121175 | Automatic Femur Segmentation And Condyle Line Detection in 3D MR Scans For Alignment Of High Resolution MR - A method for automatic femur segmentation and condyle line detection. The method includes: scanning a knee of a patient with medical imaging equipment to obtain 3D imaging data with such equipment; processing the obtained 3D imaging data in a digital processor to determine two lines tangent to the bottom of the knee condyles in an axial and a coronal plane; and automatically scanning the patient in the defined plane. The processing includes: determining an approximate location of the knee; using the determined the location to define a volume of interest; segmenting the femur in the defined volume of interest; and determining a bottom point on the femur portion on a right side and a left side of the segmented femur in an axial and a coronal slice to determine the two lines. | 2010-05-13 |
20100121176 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 2010-05-13 |
20100121177 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 2010-05-13 |
20100121178 | Systems and Methods for Automated Diagnosis and Decision Support for Breast Imaging - CAD (computer-aided diagnosis) systems and applications for breast imaging are provided, which implement methods to automatically extract and analyze features from a collection of patient information (including image data and/or non-image data) of a subject patient, to provide decision support for various aspects of physician workflow including, for example, automated diagnosis of breast cancer other automated decision support functions that enable decision support for, e.g., screening and staging for breast cancer. The CAD systems implement machine-learning techniques that use a set of training data obtained (learned) from a database of labeled patient cases in one or more relevant clinical domains and/or expert interpretations of such data to enable the CAD systems to “learn” to analyze patient data and make proper diagnostic assessments and decisions for assisting physician workflow. | 2010-05-13 |
20100121179 | Systems and Methods for Reducing RF Power or Adjusting Flip Angles During an MRI for Patients with Implantable Medical Devices - Techniques are provided for controlling magnetic resonance imaging (MRI) systems for imaging patients having implantable medical devices. In one example, a scaling factor is determined based on maximum local specific absorption rate (SAR) values for patients with implants and for patients without implants. The MRI determines the radio-frequency (RF) power and flip angle sequences to be used for a given patient, without regard to the presence of an implanted device. However, for patients with implanted devices, the MRI reduces its RF power or adjusts its flip angle sequences based on the scaling factor so as to ensure that the local SAR within the patient does not exceed acceptable levels. In other examples, rather than reducing the RF power of the MRI or adjusting the flip angles, blankets or pads formed of RF power attenuating materials, such as dielectrics, are positioned around the patient near the implantable device, to reduce the RF power incident tissues adjacent the device. | 2010-05-13 |
20100121180 | HEAD COIL FOR A MAGNETIC RESONANCE DEVICE - A head coil for a magnetic resonance apparatus has a supporting body that carries a number of antenna elements. The supporting body has an end section that is shaped as a spherical cap. A butterfly antenna is mounted at the end section, and is annularly surrounded by at least one group antenna that overlaps the butterfly antenna. | 2010-05-13 |
20100121181 | Method and System for Guidewire Tracking in Fluoroscopic Image Sequences - A method and system for tracking a guidewire in a fluoroscopic image sequence is disclosed. In order to track a guidewire in a fluoroscopic image sequence, guidewire segments are detected in each frame of the fluoroscopic image sequence. The guidewire in each frame of the fluoroscopic image sequence is then detected by rigidly tracking the guidewire from a previous frame of the fluoroscopic image sequence based on the detected guidewire segments in the current frame. The guidewire is then non-rigidly deformed in each frame based on the guidewire position in the previous frame. | 2010-05-13 |
20100121182 | SYSTEM AND METHOD FOR POSITIONING A PROBE - An adapter couples a length of optical fiber to a hollow probe and to an optical coherence tomography instrument. The length of optical fiber may be greater than the length of the adapter itself. The optical fiber is fixed to an optical coupler at a proximal end of the adapter and may be maintained in a curved configuration by features located in an internal cavity of the adapter. An optical fiber advance mechanism be used to advance and/or retract the length of optical fiber to align it within the hollow probe. | 2010-05-13 |
20100121183 | METHODS FOR MOTION COMPENSATED IMAGE RECONSTRUCTION AND SYSTEM RELATED THERETO - Featured are methods for reconstruction of images acquired from any of a number of scanning devices or apparatuses known to those skilled in the art which methods are established so as to provide a mechanism for compensating for motion of an object being imaged. Such methods of the present invention are such as to allow the clinician to select one or more specific methodologies that is appropriate for the expected motion, severity or complexity of the motion and efficient processing of projection data. Also feature are systems, apparatuses, software code and computer readable media which embody such methodologies. | 2010-05-13 |
20100121184 | SYSTEMS, METHODS AND APPARATUS FOR PREPARATION, DELIVERY AND MONITORING OF RADIOISOTOPES IN POSITRON EMISSION TOMOGRAPHY - In one aspect, systems, methods and apparatus are provided through which a dispensing station dispenses a large quantity of a radiotracer to one or more positron emission tomography imaging stations. In some aspects a quality control unit verifies the quality of the radiotracer. In some embodiments, components of the system are coupled by a local area network. In some aspects, each positron emission tomography imaging station includes an injector system, a physiological monitoring device, and a positron emission tomography scanner. All of the devices can be controlled by a computer system. | 2010-05-13 |
20100121185 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 2010-05-13 |
20100121186 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 2010-05-13 |
20100121187 | Administering a therapeutic agent with more than one taggant - A system may include a means for administering a therapeutic agent to a subject; a means for administering a first pharmaceutically-acceptable taggant to the subject at least substantially concurrent with the therapeutic agent, the first pharmaceutically-acceptable taggant having a pharmacokinetic profile; and a means for administering a second pharmaceutically-acceptable taggant to the subject with the first pharmaceutically-acceptable taggant, the second pharmaceutically-acceptable taggant having a pharmacokinetic profile different from the pharmacokinetic profile of the first pharmaceutically-acceptable taggant. | 2010-05-13 |
20100121188 | REDUCING CONTRAST AGENT-INDUCED TOXICITY - This document provides methods and materials that can be used to reduce or prevent contrast agent-induced toxicity. For example, devices for capturing contrast agents from blood are provided. | 2010-05-13 |
20100121189 | SYSTEMS AND METHODS FOR IMAGE PRESENTATION FOR MEDICAL EXAMINATION AND INTERVENTIONAL PROCEDURES - Systems and methods which provide image presentation for medical examination, interventional procedures, diagnosis treatment, etc. from multi-dimensional volume datasets are shown. Reference indicators, providing information with respect to the relationship of an image to the physical world, are preferably provided to aid a viewer in interpreting the image. Such reference indicators may be provided in the form of tool markers and corresponding image marker. Degrees of freedom provided with respect to image manipulation are preferably selectively constrained to facilitate interaction with an image or images. Embodiments of the invention may implement a relatively simple bidirectional control to facilitate a survey of an entire image volume. Image display conventions may be provided which present images in a particular orientation to facilitate user interpretation of the image. | 2010-05-13 |